Literature DB >> 35188677

Effect of high frequency versus theta-burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment-resistant depression.

Shobha Mehta1,2, Jonathan Downar2,3, Benoit H Mulsant2,4, Daphne Voineskos1,2,4, Zafiris J Daskalakis5, Cory R Weissman1,2, Fidel Vila-Rodriguez6,7, Daniel M Blumberger1,2,4.   

Abstract

OBJECTIVE: To investigate the effect of 10 Hz repetitive transcranial magnetic stimulation (rTMS) and intermittent theta-burst stimulation (iTBS) on suicidality in patients with treatment-resistant depression (TRD).
METHODS: We used data from a three-site randomized clinical trial comparing 10 Hz rTMS and iTBS applied to the left dorsolateral prefrontal cortex (DLPFC) in patients with TRD. We compared the effect of 10Hz rTMS and iTBS on suicidality as measured by the suicide item of the Hamilton Depression Rating Scale 17-item (HDRS-17).
RESULTS: Suicidality remitted in 71 (43.7%) participants randomized to 10Hz stimulation and 91 (49.1%) participants randomized to iTBS, without a significant difference between the proportions in the two groups (Χ2  = 0.674, df = 1, p = 0.4117). There was a significant correlation between change in suicidality and change in depression severity for both modalities (10 Hz, Pearson's r = 0.564; iTBS, Pearson's r = 0.502), with a significantly larger decrease in depression severity for those in whom suicidality remitted compared to those in whom it did not (t = 10.912, df = 276.8, p < 0.001).
CONCLUSIONS: Both 10 Hz and iTBS rTMS were effective in reducing suicidality in TRD. Future trials of iTBS for depression should include discrete measures of suicidality.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  brain stimulation; repetitive transcranial magnetic stimulation; suicidality; treatment-resistant depression

Mesh:

Year:  2022        PMID: 35188677      PMCID: PMC9007836          DOI: 10.1111/acps.13412

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  50 in total

1.  Functional localization in the human brain: Gradient-Echo, Spin-Echo, and arterial spin-labeling fMRI compared with neuronavigated TMS.

Authors:  Svenja Diekhoff; Kamil Uludağ; Roland Sparing; Marc Tittgemeyer; Mustafa Cavuşoğlu; D Yves von Cramon; Christian Grefkes
Journal:  Hum Brain Mapp       Date:  2011-03       Impact factor: 5.038

2.  Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial.

Authors:  Jerome A Yesavage; J Kaci Fairchild; Zhibao Mi; Kousick Biswas; Anne Davis-Karim; Ciaran S Phibbs; Steven D Forman; Michael Thase; Leanne M Williams; Amit Etkin; Ruth O'Hara; Gerald Georgette; Tamara Beale; Grant D Huang; Art Noda; Mark S George
Journal:  JAMA Psychiatry       Date:  2018-09-01       Impact factor: 21.596

Review 3.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

4.  Efficacy of theta burst stimulation (TBS) for major depression: An exploratory meta-analysis of randomized and sham-controlled trials.

Authors:  Marcelo T Berlim; Alexander McGirr; Nicole Rodrigues Dos Santos; Sara Tremblay; Ruben Martins
Journal:  J Psychiatr Res       Date:  2017-02-21       Impact factor: 4.791

5.  Neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) in treatment resistant depression.

Authors:  Daphne Voineskos; Daniel M Blumberger; Nigel C Rogasch; Reza Zomorrodi; Faranak Farzan; George Foussias; Tarek K Rajji; Zafiris J Daskalakis
Journal:  Clin Neurophysiol       Date:  2021-06-01       Impact factor: 3.708

6.  Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

Authors:  John P O'Reardon; H Brent Solvason; Philip G Janicak; Shirlene Sampson; Keith E Isenberg; Ziad Nahas; William M McDonald; David Avery; Paul B Fitzgerald; Colleen Loo; Mark A Demitrack; Mark S George; Harold A Sackeim
Journal:  Biol Psychiatry       Date:  2007-06-14       Impact factor: 13.382

7.  An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.

Authors:  Kenneth R Evans; Terrence Sills; David J DeBrota; Steve Gelwicks; Nina Engelhardt; Darcy Santor
Journal:  J Psychiatr Res       Date:  2004 May-Jun       Impact factor: 4.791

8.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

9.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

Review 10.  Management of Treatment-Resistant Depression: Challenges and Strategies.

Authors:  Daphne Voineskos; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.